The Epigenetic Modifiers HDAC2 and HDAC7 Inversely Associate with Cancer Stemness and Immunity in Solid Tumors
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25147841 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Kacper Maciejewski und 3 weiteren Autor:innen. Beteiligte Einrichtung: Undergraduate Research Group "Biobase", Poznan University of Medical Sciences, 61-701 Poznan, Poland. Hauptthemen laut MEDLINE: Histone Deacetylase 2, Neoplasms, Neoplastic Stem Cells, Histone Deacetylases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, Polish National Science Centre.
Abstract (Originalsprache)
Dysregulation of histone deacetylases (HDACs) is closely associated with cancer development and progression. Here, we comprehensively analyzed the association between all HDAC family members and several clinicopathological and molecular traits of solid tumors across 22 distinct tumor types, focusing primarily on cancer stemness and immunity. To this end, we used publicly available TCGA data and several bioinformatic tools (i.e., GEPIA2, TISIDB, GSCA, Enrichr, GSEA). Our analyses revealed that class I and class II HDAC proteins are associated with distinct cancer phenotypes. The transcriptomic profiling indicated that class I HDAC members, including HDAC2, are positively associated with cancer stemness, while class IIA HDAC proteins, represented by HDAC7, show a negative correlation to cancer stem cell-like phenotypes in solid tumors. In contrast to tumors with high amounts of HDAC7 proteins, the transcriptome signatures of HDAC2-overexpressing cancers are significantly enriched with biological terms previously determined as stemness-associated genes. Moreover, high HDAC2-expressing tumors are depleted with immune-related processes, and HDAC2 expression correlates with tumor immunosuppressive microenvironments. On the contrary, HDAC7 upregulation is significantly associated with enhanced immune responses, followed by enriched infiltration of CD4+ and CD8+ T cells. This is the first comprehensive report demonstrating robust and versatile associations between specific HDAC family members, cancer dedifferentiation, and anti-tumor immune statuses in solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Undergraduate Research Group "Biobase", Poznan University of Medical Sciences, 61-701 Poznan, Poland.
- Department of Cancer Immunology, Poznan University of Medical Sciences, 61-866 Poznan, Poland.
- Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, 61-866 Poznan, Poland.
ORCID-Profile: Kacper Maciejewski, Marek Giers, Urszula Oleksiewicz, Patrycja Czerwinska
Förderung
- National Science Center
- Polish National Science Centre
Zitieren
APA
Maciejewski, K., Giers, M., Oleksiewicz, U., & Czerwinska, P. (2024). The Epigenetic Modifiers HDAC2 and HDAC7 Inversely Associate with Cancer Stemness and Immunity in Solid Tumors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147841
Vancouver
Maciejewski K, Giers M, Oleksiewicz U, Czerwinska P. The Epigenetic Modifiers HDAC2 and HDAC7 Inversely Associate with Cancer Stemness and Immunity in Solid Tumors. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25147841
BibTeX
@article{Maciejewski2024,
author = {Maciejewski, Kacper and Giers, Marek and Oleksiewicz, Urszula and Czerwinska, Patrycja},
title = {The Epigenetic Modifiers HDAC2 and HDAC7 Inversely Associate with Cancer Stemness and Immunity in Solid Tumors},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25147841}
}
EUVIMED